Topic Review
Body Mass Index
Increased body mass index (BMI) is a risk factor for cardiovascular disease, stroke, and metabolic diseases. A high BMI may affect outcomes of post-cardiac arrest patients, but the association remains debatable.
  • 672
  • 25 Aug 2021
Topic Review
Pathophysiology of Hemorrhagic Shock
The pathophysiology of hemorrhagic shock involves a decrease in systemic oxygen delivery to a level less than what is required to maintain cellular function.
  • 672
  • 03 Nov 2021
Topic Review
Allosteric Modulation of Adenosine A2A Receptors
Adenosine is a naturally occurring purine nucleoside that regulates various physiologic functions, including inflammation and wound healing, cardiac contraction, blood vessel formation, vasodilation, learning, memory, sleep, and arousal. Adenosine is released by neurons and glial cells. Extracellular adenosine modulates neuronal excitability, synaptic plasticity, and the release and reuptake of several neurotransmitters. The effects of extracellular adenosine are modulated via four subtypes of G-protein coupled adenosine receptors (GPCRs), denoted A1, A2A, A2B, and A3. Adenosine A2A receptors (A2ARs) are broadly expressed in the brain, cardiovascular system, blood vessels, spleen, thymus, leukocytes, and lung, making them an important drug target. The therapeutic potential of targeting adenosine A2ARs is immense due to their broad expression in the body and central nervous system. The role of A2ARs in cardiovascular function, inflammation, sleep/wake behaviors, cognition, and other primary nervous system functions has been extensively studied. 
  • 672
  • 29 Mar 2022
Topic Review
Ellis-van Creveld Syndrome
Ellis-van Creveld syndrome is a rare, recessive genetic disorder. The typical signs in affected patients are dwarfism, polydactyly, dysmorphic faces and dental anomalies. 
  • 672
  • 20 Feb 2021
Topic Review
Glial Cells in Ischemia-Reperfusion Injury
Ischemic stroke is the second cause of mortality and the first cause of long-term disability constituting a serious socioeconomic burden worldwide. Approved treatments include thrombectomy and rtPA intravenous administration, which, despite their efficacy in some cases, are not suitable for a great proportion of patients. Glial cell-related therapies are progressively overcoming inefficient neuron-centered approaches in the preclinical phase. Exploiting the ability of microglia to naturally switch between detrimental and protective phenotypes represents a promising therapeutic treatment, in a similar way to what happens with astrocytes. However, the duality present in many of the roles of these cells upon ischemia poses a notorious difficulty in disentangling the precise pathways to target. Still, promoting M2/A2 microglia/astrocyte protective phenotypes and inhibiting M1/A1 neurotoxic profiles is globally rendering promising results in different in vivo models of stroke.
  • 672
  • 08 Sep 2021
Topic Review
Osteoimmunology in Periodontitis
Periodontitis is one of the most common oral diseases resulting in gingival inflammation and tooth loss. Growing evidence indicates that it results from dysbiosis of the oral microbiome, which interferes with the host immune system, leading to bone destruction. Immune cells activate periodontal ligament cells to express the receptor activator of nuclear factor kappa-B (NF-κB) ligand (RANKL) and promote osteoclast activity. Osteocytes have active roles in periodontitis progression in the bone matrix. Local proteins are involved in bone regeneration through functional immunological plasticity.
  • 672
  • 02 Jun 2022
Topic Review
Tumor Heterogeneity in ESCC
Esophageal squamous cell carcinoma (ESCC) is a common and aggressive malignancy, with hitherto dismal clinical outcome. Genomic analyses of patient samples reveal a complex heterogeneous landscape for ESCC, which presents in both intertumor and intratumor forms, manifests at both genomic and epigenomic levels, and contributes significantly to tumor evolution, drug resistance, and metastasis.
  • 674
  • 12 Oct 2021
Topic Review
Importance of GABA in the Nervous System
Normal development and function of the central nervous system involves a balance between excitatory and inhibitory neurotransmission. Activity of both excitatory and inhibitory neurons is modulated by inhibitory signalling of the GABAergic and glycinergic systems. Mechanisms that regulate formation, maturation, refinement, and maintenance of inhibitory synapses are established in early life. Deviations from ideal excitatory and inhibitory balance, such as down-regulated inhibition, are linked with many neurological diseases, including epilepsy, schizophrenia, anxiety, and autism spectrum disorders. In the mammalian forebrain, gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter, binding to GABA receptors, opening chloride channels and hyperpolarizing the cell.
  • 672
  • 29 Jul 2022
Topic Review
Nanotechnology in Viral Respiratory Infections
Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections.
  • 670
  • 05 Aug 2021
Topic Review
Magnetoencephalography (MEG) and Its Clinical Applications
MEG has two clinical applications, i.e., localization of epileptic foci and pre-operative evaluation for brain surgery candidates. MEG is also an important neuroimaging tool for the therapeutic planning of several mental disorders and abnormality analysis such as epilepsy, autism, schizophrenia, stroke, head trauma, and monitoring of drug administration
  • 672
  • 27 Jun 2022
  • Page
  • of
  • 1352
ScholarVision Creations